-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tapinarof in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tapinarof in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tapinarof in Atopic Dermatitis (Atopic Eczema) Drug Details: Tapinarof (Symbiox,...
-
Product Insights
NewLikelihood of Approval Analysis for Plaque Psoriasis (Psoriasis Vulgaris)
Overview How likely is it that the drugs in Plaque Psoriasis (Psoriasis Vulgaris) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plaque Psoriasis (Psoriasis Vulgaris) Overview Plaque psoriasis, also known as...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uracil in Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-6302 in Burns
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-6302 in Burns report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-6302 in Burns Drug Details: PXS-6302 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXS-6302 in Scar
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PXS-6302 in Scar report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PXS-6302 in Scar Drug Details: PXS-6302 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BOS-475 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BOS-475 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BOS-475 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: BOS-475 (GSK-3183475)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZEP-3 in Herpes Zoster (Shingles)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ZEP-3 in Herpes Zoster (Shingles) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ZEP-3 in Herpes Zoster (Shingles) Drug Details: Zep-3 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ZEP-3 in Herpes Labialis (Oral Herpes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ZEP-3 in Herpes Labialis (Oral Herpes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ZEP-3 in Herpes Labialis (Oral Herpes) Drug Details: Zep-3 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ivarmacitinib Sulfate in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ivarmacitinib Sulfate in Graft Versus Host Disease (GVHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ivarmacitinib Sulfate in Graft Versus Host Disease...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ivarmacitinib Sulfate in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ivarmacitinib Sulfate in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ivarmacitinib Sulfate in Crohn's Disease (Regional Enteritis) Drug Details:...